At the news
? NEUTRALIMPACT 3/10 S-3ASR filed Jun 18, 2026 at 16:09 ET
Twist Bioscience filed an automatic shelf registration (S-3ASR) including a base prospectus for various securities and a specific at-the-market (ATM) offering of up to $200M of common stock through TD Cowen. The ATM provides flexible capital-raising capacity for general corporate purposes, representing ~3.8% of the current $5.2B market cap. The filing is routine for a well-known seasoned issuer and does not indicate financial distress.
- S-3ASR filed June 18, 2026, as a well-known seasoned issuer
- Includes ATM sales agreement for up to $200M of common stock through TD Cowen
- TD Cowen commission capped at 3% of gross proceeds
- Net proceeds to be used for working capital and general corporate purposes
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access